🎉 M&A multiples are live!
Check it out!

Public Comps and Valuation Multiples
for Small Molecules

Benchmark revenue and EBITDA valuation multiples for public comps like Star Lake Bioscience, Brightgene Bio-medical, Idorsia, Sinopep and Aurisco Pharmaceutical.

Small Molecules

See analyst estimates and all valuation multiples for Small Molecules
Company EV EV/Revenue EV/EBITDA
$3.2B 7.2x 19.5x
$3.1B 17.6x 57.1x
$2.2B 19.4x -31.6x
$2.1B 2.8x 15.9x
$1.8B 0.7x 5.7x
$1.8B 7.1x 17.4x
$1.7B 11.0x -5.4x
$1.5B 57.6x -41.9x
$1.2B 5.3x 15.8x
$1.1B 5.1x 25.1x
$801M n/a n/a
$787M n/a n/a
$760M 3.5x 119.9x
$635M 3.2x 13.6x
$584M 6.9x 20.3x
$356M 4.8x n/a
$344M 340.0x -2.0x
$319M 1.7x 8.9x
$209M n/a n/a
$182M n/a -8.5x
$166M 6.1x -6.6x
$127M 1767.1x -27.4x
$106M 1.1x -10.3x
$71.4M 1.4x n/a
$33.3M n/a -0.2x
$16.6M 1.3x n/a
-$27.6M -34.0x 0.3x
-$32.6M -0.4x 0.3x
-$37.1M -8.3x n/a
-$37.2M n/a n/a
-$46.3M -1.5x 0.4x
-$130M n/a n/a
-$243M -5.6x 1.3x

Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.

See analyst estimates and M&A multiples for Small Molecules

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.